Profil
Stacey Bain is currently a Director at Catalyst Canada, Inc. Prior to this, she held positions as Vice President-Clinical Product Development at BioNumerik Pharmaceuticals, Inc. and Vice President-Clinical Operations at Acer Therapeutics, Inc. She received a doctorate degree from Texas A&M University in 1998 and an undergraduate degree from the same institution in 1992.
Postes actifs de Stacey Bain
| Sociétés | Poste | Début |
|---|---|---|
Catalyst Canada, Inc.
Catalyst Canada, Inc. Advertising/Marketing ServicesCommercial Services Provides marketing and advertising services | Directeur/Membre du Conseil | - |
Anciens postes connus de Stacey Bain
| Sociétés | Poste | Fin |
|---|---|---|
| ACER THERAPEUTICS INC. | Directeur Technique/Scientifique/R&D | - |
BioNumerik Pharmaceuticals, Inc.
BioNumerik Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops new medicines for cancer treatment | Corporate Officer/Principal | - |
Formation de Stacey Bain
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
BioNumerik Pharmaceuticals, Inc.
BioNumerik Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops new medicines for cancer treatment | Health Technology |
Texas A&M University
Texas A&M University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Catalyst Canada, Inc.
Catalyst Canada, Inc. Advertising/Marketing ServicesCommercial Services Provides marketing and advertising services | Commercial Services |
Acer Therapeutics, Inc.
Acer Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops and commercializes therapies for serious rare and life-threatening diseases | Health Technology |
















